Resources We partner with pharma to advance neuroscience research All ResourcesConferencesPress ReleasesIn the newsPublications AxoSim Posters Featured at SOT 2024 Annual Meeting March 26, 2024 | Conferences Read More → AxoSim Appoints Two Biotech Industry Veterans as Co-Chairs of Its Board of Directors February 28, 2024 | Press Releases Read More → Fierce Biotech: Organoids touted as future of brain disorder R&D as AxoSim scoops up tech from Vyant subsidiary December 15, 2023 | In the news Read More → Latest Acquisition Lands AxoSim in the News November 28, 2023 | In the news Read More → AXOSIM EXTENDS LEADERSHIP IN HUMAN ORGANOIDS FOR NEUROLOGICAL DRUG DISCOVERY WITH ACQUISITION OF STEMONIX MICROBRAIN™ TECHNOLOGY October 31, 2023 | Press Releases Read More → AxoSim Enters Into a Definitive Agreement to Acquire Vyant Bio’s StemoniX Assets July 17, 2023 | Press Releases Read More → Nola.Com Op-Ed Featuring AxoSim CEO Lowry Curley, PhD October 25, 2022 | In the news Read More → AxoSim CEO Quoted in Cover Story for GEN: Genetic Engineering and Biotechnology News July 19, 2021 | In the news Read More → Advances in 3D neuronal microphysiological systems: towards a functional nervous system on a chip January 18, 2021 | Publications Read More → « Previous 1 2 3 4 Next »
